Glass House Rings the Bell at the NYSE | TTB on Location

In our latest Trade to Black podcast, hosts Shadd Dales and Anthony Varrell head back to the New York Stock Exchange for the second time this month, this time to witness Glass House Brands (NYSE: GLAS) ring the bell after trading on a senior U.S. exchange for a little over two months. CEO Kyle Kazan and President Graham Farrar made the trip from California along with nearly 100 investors, employees, and longtime supporters, a sign of just how far Glass House has come since starting as a small private equity investment back in 2015. Kazan breaks down what medical cannabis moving to Schedule III could mean for interstate and international commerce, why Glass House sees itself less as a competitor to MSOs and more as a wholesale supply partner, "the Intel inside" as he puts it, and why he believes price normalization is coming for markets like Georgia, where cannabis currently sells for roughly ten times California pricing. Farrar adds his own perspective on where the plant itself is headed, arguing potency chasing is really an artifact of prohibition, and that as the category normalizes, consumers will shift toward flavor, effect, and wellness use the same way people choose a favorite beer or spirit rather than the strongest one available. The episode also features conversations with Head of Capital Markets John de DeCourcey on institutional sentiment building around Trulieve (NYSE: TRLV) and Glass House both, AdvisorShares CEO Dan Ahrens on rising volume across MSOS (NYSE: MSOS) holdings, and Aaron discussing why real mainstream recognition, not just industry buzz, is still needed before this rescheduling moment truly registers with the broader investing public. 00:00:00 — Glass House Rings NYSE Bell 00:01:37 — Cannabis Industry Moves Toward Normalization 00:04:32 — International Cannabis Expansion Takes Shape 00:05:49 — Interstate Commerce Could Change Everything 00:09:53 — Institutional Investors Back Glass House 00:10:53 — Interstate and International Commerce Ahead 00:15:48 — Institutional Interest Continues Building 00:17:15 — Schedule III Opens Interstate Door 00:19:54 — Cannabis Stocks Regain Momentum 00:21:11 — Uplisting Expands Investor Access 00:23:31 — Cannabis Companies Draw New Interest 00:23:55 — California Cannabis Goes Global 00:25:37 — Cannabis Moves Beyond High Potency 00:26:50 — Cannabis Enters Medicine Cabinet 00:28:02 — Interstate Cannabis Dominoes Could Fall 00:29:04 — NYSE Brings Cannabis Legitimacy 00:31:47 — What Comes Next for Cannabis #TradeToBlack #GlassHouseBrands #NYSE #Trulieve #MSOS #CannabisUplisting #CannabisStocks #CannabisRescheduling #KyleKazan #CannabisNews Want to see more Cannabis Reform? 🎬    • Why This Tax Case Matters for Cannabis Res...   🎬    • Trump's Rescheduling Push Meets a New Bill...   🎬    • Legal Weed Could Bring in $58 Billion More...   🎬    • Regulate Hemp, Don't Destroy It, Says CEO ...   Want to stay updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked newsletter: https://newsletter.thedalesreport.com... Find us on social media and podcast platforms: ✅ Facebook:   / thedalesreport   ✅ Twitter:   / thedalesreport   ✅ Instagram:   / dalesreport   ✅ LinkedIn:   / the-dales-report   Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon... Spotify: https://tinyurl.com/TDRTradeToBlackon... Website: https://thedalesreport.com/ For copyright matters, contact: sdales@thedalesreport.com Podcast Disclaimer (Financial Interests) The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice. The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions. By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed. Full Disclosures: https://thedalesreport.com/website-te...